Cargando…

FACTORS AFFECTING OUTCOMES IN PATIENTS WITH SEVERE COVID-19 WHO RECEIVED CONVALESCENT PLASMA THERAPY

Detalles Bibliográficos
Autores principales:	SRIDEVI, T., SUBRAMANIAM, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212367/ http://dx.doi.org/10.1016/j.chest.2021.12.170

Ejemplares similares

BLOOD TYPE AND MALE SEX AS POTENTIAL PREDICTORS OF SUSCEPTIBILITY, SEVERITY, AND OUTCOMES IN COVID-19
por: MA, EVA, et al.
Publicado: (2021)

THE IMPACT OF COVID-19 VACCINATION ON DISEASE SEVERITY AND OUTCOMES IN HOSPITALIZED PATIENTS: A REAL-WORLD EXPERIENCE
por: SATISH, V., et al.
Publicado: (2022)

COMPARISON OF SEVERITY AND CLINICAL OUTCOMES OF PATIENTS WITH COVID-19 FROM MULTIETHNIC BACKGROUNDS IN A TERTIARY CARE CENTER
por: SELVARAJ, J., et al.
Publicado: (2022)

TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA
por: AHMED, MUBASHIR AYAZ, et al.
Publicado: (2022)

Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial
por: Self, Wesley H., et al.
Publicado: (2022)

UNEXPECTED OPPORTUNISTIC INFECTION IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: NIEVES, HÉCTOR, et al.
Publicado: (2021)

ATYPICAL PAROTITIS AS A RESULT OF SEVERE COVID-19 INFECTION
por: MARCANO, ANDREW, et al.
Publicado: (2021)

SEVERE/REFRACTORY IMMUNE THROMBOCYTOPENIA IN MILD COVID-19 DISEASE
por: MENON, TRISHALA, et al.
Publicado: (2021)

PLASMA EXCHANGE IN THE TREATMENT OF THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH COVID-19 INFECTION: A CASE REPORT
por: Logan, Danielle, et al.
Publicado: (2020)

SPECTRUM OF COVID-19 SEVERITY IN YOUNG ADULTS: A CASE SERIES
por: Riera, Maria Bernal, et al.
Publicado: (2020)

GIRAFFE IN THE COVID-19 LUNG: PULMONARY FIBROSIS LIMITING SEVERITY OF THE PNEUMOTHORAX
por: ALLEN CHAN, MARVYN, et al.
Publicado: (2021)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

CASE REPORT OF SEVERE PULMONARY FIBROSIS AS A SEQUELAE OF COVID-19 INFECTION
por: Arjun, Shiva, et al.
Publicado: (2020)

CATASTROPHIC STROKE DESPITE ASPIRIN AND THERAPEUTIC ENOXAPARIN IN PATIENT WITH SEVERE COVID-19
por: Condit, Daniel, et al.
Publicado: (2020)

SEVERE ALLERGIC ERYTHEMATOUS REACTION POSTMESSENGER RNA-BASED COVID-19 VACCINE
por: ALI, RUHMA, et al.
Publicado: (2022)

CLINICAL OUTCOMES OF PATIENTS WITH ASTHMA WITH COVID-19 PNEUMONIA
por: Brinton, Taylor, et al.
Publicado: (2020)

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

POST-COVID-19 SYNDROME: CHARACTERIZATION OF A COHORT AND ASSOCIATION WITH ACUTE DISEASE SEVERITY
por: OLIVEIRA BAPTISTA DA SILVA, FERNANDA, et al.
Publicado: (2021)

PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: AIYANYOR, ALFRED, et al.
Publicado: (2021)

SINUS BRADYCARDIA AS A PREDICTOR OF SEVERITY OF COVID-19 INFECTION: TRANQUILITY BEFORE CHAOS
por: ARSALAN ZAIDI, SYED, et al.
Publicado: (2021)

PREDICTING COVID-19 SEVERITY USING A SIMPLE PARAMETERS IN RESOURCE-LIMITED SETTINGS
por: NIMITVILAI, S., et al.
Publicado: (2022)

PROTECTIVE FACTORS AGAINST THE COVID-19 STORM
por: Kang, James, et al.
Publicado: (2020)

PROCALCITONIN AS A PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS WITH COVID-19
por: JACKSON, IAN, et al.
Publicado: (2021)

OUTCOMES OF PATIENTS WITH COVID-19 ON ANTIHYPERTENSIVE MEDICATIONS IN SOUTHERN PENNSYLVANIA
por: CHAN, VERNON, et al.
Publicado: (2021)

BLOODSTREAM INFECTIONS AMONG PATIENTS WITH COVID-19: EPIDEMIOLOGY AND OUTCOME
por: NIMITVILAI, S., et al.
Publicado: (2022)

FERRITIN-GUIDED THERAPEUTIC PLASMA EXCHANGE (TPE) ADMINISTRATION IN COVID-19-INDUCED CYTOKINE STORM SYNDROME: A CASE SERIES
por: MASI, SEAN M, et al.
Publicado: (2022)

METEOROLOGICAL FACTORS ASSOCIATED WITH THE SPREAD OF THE COVID-19 VIRUS
por: Rios, Gabriel, et al.
Publicado: (2020)

OUTCOMES OF COVID-19 INFECTION: COMMUNITY-BASED RETEROSPECTIVE COHORT STUDY
por: AL-GHOULA, FAYSAL, et al.
Publicado: (2021)

WORSE OUTCOMES OF VARIANT COVID-19 VIRUSES IN CHRONIC HEMODYALISYS PATIENTS
por: WAND, ORI, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOME OF PNEUMOMEDIASTINUM AND PNEUMOTHORAX IN PATIENTS WITH COVID-19 PNEUMONIA
por: RANA, VISHAL, et al.
Publicado: (2021)

INCIDENCE, CLINICAL CHARACTERISTICS, AND OUTCOMES OF PATIENTS WITH COVID-19 AND FUNGAL COINFECTION
por: SWANEY, RICHARD, et al.
Publicado: (2022)

PROTECTIVE EFFECT OF HIGHER AMBIENT OZONE LEVELS ON COVID-19 OUTCOMES
por: SINGH, HARJEET, et al.
Publicado: (2022)

E. COLI PNEUMONIA WITH PNEUMATOCELE, EMPYEMA NECESSITANS, AND BRONCHOPLEURAL FISTULA IN A PATIENT WITH SEVERE COVID-19
por: Kahn, Michael, et al.
Publicado: (2020)

PREDICTORS AND OUTCOMES OF BACTERIAL AND FUNGAL SUPERINFECTIONS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: YAQOOB, HAMID, et al.
Publicado: (2021)

OUTCOMES OF WHITE VS MINORITY PATIENTS WITH COVID-19 WITH ARDS TREATED WITH ECMO
por: REDDY, RENUKA, et al.
Publicado: (2021)

TNF/IFN-GAMMA AXIS FAVORS SENESCENCE AND SEVERE INFLAMMATION ASSOCIATED WITH CELL DEATH IN PATIENTS WITH COVID-19
por: PALACIOS, Y., et al.
Publicado: (2022)

SEVERE PULMONARY BLASTOMYCOSIS IN A PATIENT WITH A COVID-19-POSITIVE TEST: A DANGEROUS ANCHORING BIAS
por: DURDEVIC, MOMCILO, et al.
Publicado: (2022)

OUTCOMES FOR BLACK AND HISPANIC PATIENTS WITH COVID-19: A LARGE HEALTHCARE SYSTEM EXPERIENCE
por: RAO, ANIRUDH, et al.
Publicado: (2021)

IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER USE OF ANTI-RETROVIRAL THERAPY IN COVID-19
por: NANGRANI, KUNAL, et al.
Publicado: (2021)

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ISOLATION FROM PLEURAL FLUID WITH COVID-19 PNEUMONIA AND SUPERIMPOSED EMPYEMA
por: Leys, Lorenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ttscmhu56cgfntsbhnub01lq6